Steve Weinrauch, EVP of North America & Veterinary Strategy, has demonstrated a consistent pattern of selling shares in Trupanion, Inc. (TRUP), as evidenced by SEC Form 4 filings. Over the course of 45 transactions, Weinrauch has exclusively sold shares, with no recorded purchases, totaling $193,949.07 in value. His trading activity is concentrated entirely within Trupanion, indicating a focused relationship with the company. Recent filings highlight a continuation of this trend, with a notable sale on February 25, 2026, valued at $2,269.50, and additional transactions on the same date totaling $3,684.60. Earlier in February 2026, Weinrauch executed larger sales, including one on February 22 worth $16,323.16 and another on the same day valued at $23,602.04. This pattern extends back to late 2025, with significant sales on November 24 and 25, including transactions worth $17,487.60 and $25,240.20, respectively. Weinrauch’s consistent divestment of TRUP shares suggests a strategic reduction in his holdings, though the filings provide no indication of the underlying rationale. The absence of buying activity underscores a clear bias toward selling, reflecting a deliberate approach to managing his equity position in Trupanion.
AI-assisted summary